146 related articles for article (PubMed ID: 17297203)
1. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients.
Syamsu ; Yusuf I; Budu ; Patellongi I
Acta Med Indones; 2007; 39(1):8-12. PubMed ID: 17297203
[TBL] [Abstract][Full Text] [Related]
2. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
3. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphism of beta 2-adrenergic receptors].
Weglarz L; Grzanka A; Kierot J; Wilczok T
Wiad Lek; 2003; 56(5-6):283-8. PubMed ID: 14526489
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
Hancox RJ; Sears MR; Taylor DR
Eur Respir J; 1998 Mar; 11(3):589-93. PubMed ID: 9596107
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the β2-adrenergic receptor correlated to nocturnal asthma and the response of terbutaline nebulizer.
Lee MY; Cheng SN; Chen SJ; Huang HL; Wang CC; Fan HC
Pediatr Neonatol; 2011 Feb; 52(1):18-23. PubMed ID: 21385652
[TBL] [Abstract][Full Text] [Related]
8. Beta2-adrenoceptor polymorphisms predict response to beta2-agonists in children with acute asthma.
Martin AC; Zhang G; Rueter K; Khoo SK; Bizzintino J; Hayden CM; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN
J Asthma; 2008 Jun; 45(5):383-8. PubMed ID: 18569231
[TBL] [Abstract][Full Text] [Related]
9. A genetic twist to the beta-agonist 'debate'.
Walters EH; Walters JA
Clin Sci (Lond); 1999 Mar; 96(3):219-20. PubMed ID: 10366288
[No Abstract] [Full Text] [Related]
10. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
Chung LP; Waterer G; Thompson PJ
Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
[TBL] [Abstract][Full Text] [Related]
12. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.
van Veen A; Wierenga EA; Westland R; Weller FR; Hart GA; Jansen HM; Jonkers RE
Respir Res; 2006 Jan; 7(1):19. PubMed ID: 16448568
[TBL] [Abstract][Full Text] [Related]
13. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
Metzger NL; Kockler DR; Gravatt LA
Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
[TBL] [Abstract][Full Text] [Related]
14. Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients.
Asano K; Yamada-Yamasawa W; Kudoh H; Matsuzaki T; Nakajima T; Hakuno H; Hiraoka R; Fukunaga K; Oguma T; Sayama K; Yamaguchi K; Nagabukuro A; Harada Y; Ishizaka A
Respirology; 2010 Jul; 15(5):849-54. PubMed ID: 20546196
[TBL] [Abstract][Full Text] [Related]
15. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
16. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.
Dishy V; Sofowora GG; Xie HG; Kim RB; Byrne DW; Stein CM; Wood AJ
N Engl J Med; 2001 Oct; 345(14):1030-5. PubMed ID: 11586955
[TBL] [Abstract][Full Text] [Related]
17. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic tests in asthma therapy.
Yu IW; Bukaveckas BL
Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
[TBL] [Abstract][Full Text] [Related]
19. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
Bruck H; Leineweber K; Beilfuss A; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2003 Sep; 74(3):255-63. PubMed ID: 12966369
[TBL] [Abstract][Full Text] [Related]
20. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]